COL18A1 and renal cell carcinoma: Next, cell function experiments showed knocking down KLF12 reversed the negative roles of COL18A1-AS1 on the proliferation, migration, and invasion ability of RCC cells (Fig. 6C–F and Supplementary Fig. 9C–F).